Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |